| Burkina Faso | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 112.0 (2020) [148/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 6.5 (2020) [57/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.2 (2020) [149/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 32.7 (2020) [140/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 18.2 (2020) [67/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 2.0 (2020) [182/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 8.0 (2020) [85/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.4 (2020) [125/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.3 (2020) [137/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.5 (2020) [173/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 3.0 (2020) [141/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.7 (2020) [110/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 10.9 (2020) [25/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 2.0 (2020) [176/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 3.3 (2020) [105/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.2 (2020) [99/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.1 (2020) [161/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 2.2 (2020) [177/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 2.1 (2020) [107/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.2 (2020) [135/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 7.8 (2020) [49/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 3.1 (2020) [110/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 35.9 (2020) [98/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 2.9 (2020) [167/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.5 (2020) [129/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 0.8 (2020) [166/184countries] | | |
|
| Burkina Faso | | |
Suicide, age-standardized (per 100 000 population) | 14.38 (2019) [33/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 24.45 (2019) [30/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 6.50 (2019) [34/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 5.04 (2019) [98/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 7.14 (2019) [101/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.87 (2019) [79/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 7.85 (2019) [86/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 11.90 (2019) [87/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.75 (2019) [68/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 11.46 (2019) [71/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 18.68 (2019) [67/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.41 (2019) [74/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 21.95 (2019) [33/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 37.55 (2019) [30/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 7.87 (2019) [59/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 34.37 (2019) [17/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 57.96 (2019) [14/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 15.91 (2019) [19/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 54.17 (2019) [8/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 94.94 (2019) [7/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 26.92 (2019) [12/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 70.02 (2019) [11/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 129.90 (2019) [9/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 33.92 (2019) [16/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 218.20 (2019) [4/183countries] | | |
|
|